IDI Jobs

Research Fellow (3)

General Summary

ACCEPT-Africa Targeted Research Awards for Epidemic and Pandemic Preparedness

Background

The African Consortium for Clinical Evidence, Pharmacology and Translational Research (ACCEPT-Africa) is a multidisciplinary, multi-country research consortium under the Africa Pandemic Sciences Collaborative (EPSILON-1). Led by the Infectious Diseases Institute (IDI), Makerere University, Uganda, ACCEPT-Africa brings together research institutions and investigators from Uganda, Tanzania (Kibong’oto Infectious Diseases Hospital), the Democratic Republic of Congo (Catholic University of Bukavu), South Africa (University of Cape Town), and Italy (University of Turin) to strengthen Africa's capacity to develop, evaluate, and deploy medical countermeasures for epidemic- and pandemic-prone diseases.

ACCEPT-Africa integrates expertise in early-phase clinical trials, clinical pharmacology, pharmacokinetics/pharmacodynamics (PK/PD), implementation science, infectious diseases, laboratory sciences, regulatory science, and epidemic preparedness.

The consortium is guided by three strategic objectives:

Advance the clinical development of medical countermeasures targeting priority pathogens;
Strengthen epidemic–pandemic research ecosystems; and
Build sustainable capacity for early-phase clinical trials targeting priority pathogens.

To advance these objectives, ACCEPT-Africa invites applications from individual researchers for Targeted Research Awards addressing priority scientific and operational gaps relevant to medical countermeasure development and epidemic clinical research.

Purpose of the Call

The ACCEPT-Africa Targeted Research Awards will provide catalytic funding for focused, high-impact and implementation-oriented research projects that can generate preliminary evidence, address critical knowledge or methodological gaps, strengthen existing research platforms, and contribute to the development and evaluation of medical countermeasures for priority pathogens.

A total of three awards will be available, with funding of up to US$15,000 per project for an implementation period of up to 12 months.

The call is specifically intended to support research that can leverage existing ACCEPT-Africa platforms, cohorts, protocols, laboratory capabilities, partnerships and research infrastructure to achieve clearly defined outputs within the award period.

Applicants must submit a proposal addressing one of the three priority research areas below.

Priority Research Areas

Priority Area 1: Pharmacokinetics of drugs used for diseases of outbreak potential

Priority Area 2: Biomarkers and diagnostics for drug development which could be viral, immunological or other markers that can be used to assess treatment response or severity of highly infectious diseases of outbreak potential

Priority Area 3: Social and Behavioral Research on Epidemic Clinical Trials

Funding Available

ACCEPT-Africa intends to make three competitive research awards, subject to satisfactory scientific review and availability of funds.

Maximum Award

Each successful project may receive funding of up to US$15,000.

Applicants are expected to submit realistic and well-justified budgets directly linked to the proposed research activities and outputs.

Eligible costs may include research personnel support, laboratory reagents and consumables, sample processing and analysis, data collection, participant-related research costs, field activities, data management and analysis, stakeholder/community engagement directly related to the research, and dissemination of findings.

Major capital equipment and costs not directly attributable to delivery of the proposed research should generally not constitute a substantial proportion of the requested budget.

Application Requirements

Applicants should submit a concise application package containing:

CV and personal statement (use the NIH template)
2 letters of recommendations (ACCEPT-Africa site PI and one proposed mentor)
Proposal (download the template.docx)
Budget (maximum US$15,000)

Key Timelines

Milestone	Date/Period
Call opens	September 2026
Application deadline	16th October 2026
Scientific and technical review	November 2026
Notification of successful applicants	Late November 2026
Anticipated project commencement	December 2026

Applications must be received by 16th October 2026. Late or substantially incomplete applications will not be considered.

Key Responsibilities

Successful applicants will be expected to:

Implement the approved research within 12 months;
Achieve agreed milestones and deliverables;
Participate in relevant ACCEPT-Africa scientific meetings and research forums;
Participate in the monthly catalyst groups
Present twice a year at the trainees’ evaluation meetings
Provide periodic technical and financial progress reports on iBRDGE;
Comply with consortium research governance and data-management requirements;
Produce at least one substantive scientific output, such as a manuscript, protocol/SOP, technical report, policy/implementation brief or conference abstract; and
Develop, where appropriate, a pathway for translating findings into a larger study, clinical trial, medical countermeasure development program, policy or practice.

Authorship, data access, intellectual property, sample governance and publication arrangements will be managed in accordance with applicable institutional and ACCEPT-Africa policies.

Academic Qualifications

Masters in any biomedical or Health Sciences related field
Enrolled in a post-graduate degree in any biomedical or Health Sciences related field

Person Specification

Applicants must:

Be affiliated with a recognized university, research institution, healthcare institution, public health agency or other eligible scientific institution
Demonstrate relevant expertise or a strong research track record/potential in the selected priority area
Demonstrate access to, or a credible pathway for accessing the facilities, platforms, samples, populations, datasets or other resources necessary to undertake the proposed research
Demonstrate the ability to complete the proposed project within 12 months
Identify an institutional mechanism capable of receiving and administering the research award
Comply with applicable institutional, national and ACCEPT-Africa scientific, ethical, regulatory, biosafety, data and research governance requirements; and
Be willing to collaborate with ACCEPT-Africa investigators and relevant national, regional and institutional partners.

Researchers and investigators seeking to establish independent research projects, are strongly encouraged to apply.

Collaborative proposals are encouraged; however, the application must identify one individual researcher as the Principal Applicant and award lead.

More Details

Job Code: RFW003
No of Position: 3
Station: Mulago
Classification: Scholar
Duration: 12 Months
Reports to: Capacity Building Scientist
Posted Date: 2026-09-23 14:42:11.000
Closing Date: 2026-10-16 17:00:00.000

Job Code:
No of Position:
Station:
Classification:
Duration:
Reports to:
Capacity Building Scientist
Posted Date:
Closing Date:

Other Jobs

IDM-Africa fellow (3)

1. About IDM-Africa

Sub-Saharan Africa needs more local infectious-disease modellers to generate evidence for outbreaks, antimicrobial resistance and other public-health priorities. IDM-Africa is a Strategic Training Hub that will build this capacity through Workshops for early- and mid-career researchers and one-year mentored Fellowships for advanced modellers. Fellows will develop locally relevant modelling projects and translate findings into scientific papers, policy briefs and practical recommendations. The programme combines hands-on learning, expert mentorship and sustained peer support to strengthen African modelling leadership and institutional capacity.

2. Fellowship Program Overview

IDM-Africa invites applications from early- and mid-career scientists in sub-Saharan Africa (SSA) for its annual Fellowship Programme in infectious-disease modelling. The Fellowship supports scientists who already have foundational training and practical experience in infectious-disease modelling to develop an applied, policy-relevant modelling project using their own data. Fellows will receive structured mentorship from leading modellers, infectious-disease experts and policy specialists at partner institutions. The partner sites are The Infectious Diseases Institute (IDI) at Makerere University; University of Sciences, Techniques and Technologies of Bamako (USTTB) and Amsterdam University Medical Center (UMC) with their corresponding training sites being The African Center of Excellence in Bioinformatics and Data-Intensive Sciences, Kampala-Uganda (ACE-Uganda); The African Center of Excellence in Bioinformatics and Data-Intensive Sciences, Bamako-Mali (ACE-B); and The Amsterdam Institute for Global Health and Development (AIGHD).

3. Fellowship Structure

Each Fellowship runs for 12 months:

One month of in-person placement at the selected host institution (ACE-Uganda or ACE-B), with intensive mentor-guided project development.
Eleven months of online mentorship, including at least one mentor-mentee session every two weeks, peer-learning activities, monthly progress reporting, and quarterly review meetings.

Fellows should be able to commit 100% FTE for month 1 and approximately 4 hours a day (50% FTE) to Fellowship activities during the online mentorship period.

During the Fellowship, participants will refine their research question; prepare and analyse data; develop, test and interpret infectious-disease models; strengthen reproducible research practice; receive code and data-review support; develop scientific-writing and policy-communication skills; and engage with public-health stakeholders where relevant.

For this round, we are recruiting three (3) fellows as follows:

Two (2) Positions at IDI / ACE-Uganda (Open to candidates who are fluent in English, including those from non-Anglophone SSA countries)
One (1) Position at ACE-Mali / USTTB (Open to candidates who are fluent in French, including those from non-Francophone SSA countries)

EPIDEMIOLOGIST (2)

The Epidemiologist leads disease surveillance, data analysis, and outbreak investigation activities within an assigned area, ensuring timely detection, verification, and response to public health events at Points of Entry (PoE) and border communities. The role provides technical leadership to district and PoE-level teams and ensures high-quality epidemiological data informs decision-making.

Technical Officer - Laboratory (2)

The laboratory technical officer will support Laboratory Sample management, Testing and Biosafety Biosecurity measures, daily analysis for patient samples for differential diagnoses, process control, Corrective Action and Preventive Action, laboratory documentation and compile daily updates on laboratory performance.

Technical officer - Infection prevention and control (2)

The candicate will provide technical support to implement infection prevention and control at national, subnational and district level. The position involves strengthening IPC capacity related to routine service delivery and outbreaks responses at different levels

Senior technical officer - case management (3)

The technical case management officer will work closely with the response teams to provide technical and operational support for the delivery of safe, timely and high-quality case-management services during disease outbreaks and other public-health emergencies.

M&E SPECIALIST (1)

The Monitoring and Evaluation Specialist will be support to design, implement and review of the project’s monitoring and evaluation interventions. She/he will ensure data-driven decision-making by producing high-quality evidence to support project planning, implementation, learning, and reporting. The role requires strong analytical and communication skills, experience with data systems, and a commitment to strengthening GHS outcomes.

LAB RUNNER/MESSENGER (1)

The Lab Runner will provide day-to-day support to the study team by ensuring the safe, timely, and accurate movement of laboratory samples, documents, supplies, and other study materials between designated study areas, laboratories, and other authorised locations.

The position will support smooth laboratory operations while maintaining sample integrity, confidentiality, safety and compliance with study and laboratory procedures.